China SXT Pharmaceuticals Inc
Research China SXT Pharmaceuticals Inc (SXTC) on Bullrun: market cap USD 127.17K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSXTC
- ExchangeNASDAQ
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 127.17K
- Financial periodFY2026
- RevenueUSD 1.14M
- Revenue growth-34.6%
- Net income-USD 6.21M
- Free cash flow-USD 5.27M
- Gross margin21.9%
Valuation Snapshot
latest market cap is USD 127.17K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 1.14M | -USD 6.21M | -USD 5.27M | 21.9% | n/a | USD 28.18M | USD 1.12M | USD 29.71M |
| FY2025 | USD 1.74M | -USD 3.30M | -USD 2.35M | 21.1% | -348.15 | USD 18.10M | USD 983.88K | USD 15.44M |
| FY2024 | USD 1.93M | -USD 3.10M | -USD 1.94M | 28.7% | -1676.69 | USD 12.07M | USD 2.65M | USD 13.93M |
| FY2023 | USD 1.97M | -USD 5.93M | -USD 151.44K | 21.6% | -15576.83 | USD 17.37M | USD 3.76M | USD 14.69M |
| FY2022 | USD 2.60M | -USD 5.74M | USD 205.80K | 48.1% | -85613.36 | USD 15.52M | USD 2.05M | USD 16.42M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 127.17K | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 185.64M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 259.08K | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 357.30K | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 203.25K | n/a | n/a | n/a |
About China SXT Pharmaceuticals Inc
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is China SXT Pharmaceuticals Inc's market cap?
China SXT Pharmaceuticals Inc's market capitalization is USD 127.17K.
What does China SXT Pharmaceuticals Inc do?
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.